Publications ASD

Publications

Comparison of the Occlutech Figulla Septal Occluder and Amplatzer Septal Occluder for Atrial Septal Defect Device Closure

Supaporn Roymanee • Worakan Promphan • Nakharin Tonklang • Kanjarut Wongwaitaweewong Download PDF

Publications

Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis (Apr 2020)

Aparisi A., et al.

Publications

Clinical Significance of Septal Malalignment for Transcatheter Closure of ASDs (Mar 2020)

Takaya Y., et al.

Publications

Percutaneous ASD Closure Using the Occlutech Figulla Device in Adults – More than 800 Patient-Years of Follow-Up (Feb 2020)

Snijder R. J. R., et al.

Publications

Percutaneous closure of a large atrial septal defect in a child with severe dextroscoliosis: A case report (May 2019)

Linte A., et al.

Publications

A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of ASDs (Nov 2018)

Kenny D., et al.

Publications

Use of Occlutech® Fenestrated Atrial Septal Defect Occluder in ASD-Associated Pulmonary Arterial Hypertension (May 2017)

P. Samuel B., et al.

Publications

Techniques for Transcatheter Retrieval of the Occlutech ASD Device United Kingdom–European Multicenter Report (Dec 2016)

O Shebani S., et al.

Publications

Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Serie (Mar 2016)

A. Haas N., et al.

Publications

Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device (Mar 2016)

A.C. Pedra C., et al.

Showing Slide 1 of 11

The products shown may not be available in all markets. Availability for a specific therapeutic purpose, in any specific country or region, is subject to obtaining necessary regulatory clearance.